Change 5-day change 1-year change 3-year change Capi.($)
+2.42%-.--% - - 0
+0.17%-2.05%+58.46%+108.71% 1,034B
+1.17%+1.61%+54.08%+70.75% 654B
+0.26%-0.84%+23.01%+78.43% 459B
+0.49%-5.19%+33.28%+35.53% 343B
+0.27%+3.26%+29.76%+47.50% 307B
+0.12%-2.11%+0.60%+12.03% 251B
+0.49%+0.02%+53.50%+73.39% 237B
+2.64%-1.08%-15.85%-53.97% 202B
-0.19%+1.14%+32.89%+99.27% 186B
Average +0.79%-2.88%+29.97%+52.40% 407.95B
Weighted average by Cap. +0.53%-3.31%+38.85%+67.92%
Logo Shire
Shire specializes in developing, producing, and marketing pharmaceutical products for the treatment of nervous system dysfunctions (hyperactivity, epilepsy, Alzheimer's disease, etc.), cancer, gastro-intestinal illnesses, and infectious diseases. Net sales break down by source of income as follows: - sales of products (95.3%); - other (4.7%): primarily franchise royalties. Net sales break down geographically as follows: the United States (63.6%), Ireland (0.4%) and other (36%).
Employees
-